FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311662008> ?p ?o ?g. }

• W4311662008 endingPage "767" @default.
• W4311662008 startingPage "754" @default.
• W4311662008 abstract "Sodium-glucose cotransporter 2 (SGLT2) inhibitors are widely used in the treatment of type 2 diabetes, heart failure and chronic kidney disease. Their role in the prevention of diet-induced metabolic deteriorations, such as obesity, insulin resistance and fatty liver disease, has not been defined yet. In this study we set out to test whether empagliflozin prevents weight gain and metabolic dysfunction in a mouse model of diet-induced obesity and insulin resistance.C57Bl/6 mice were fed a western-type diet supplemented with empagliflozin (WDE) or without empagliflozin (WD) for 10 weeks. A standard control diet (CD) without or with empagliflozin (CDE) was used to control for diet-specific effects. Metabolic phenotyping included assessment of body weight, food and water intake, body composition, hepatic energy metabolism, skeletal muscle mitochondria and measurement of insulin sensitivity using hyperinsulinaemic-euglycaemic clamps.Mice fed the WD were overweight, hyperglycaemic, hyperinsulinaemic and insulin resistant after 10 weeks. Supplementation of the WD with empagliflozin prevented these metabolic alterations. While water intake was significantly increased by empagliflozin supplementation, food intake was similar in WDE- and WD-fed mice. Adipose tissue depots measured by MRI were significantly smaller in WDE-fed mice than in WD-fed mice. Additionally, empagliflozin supplementation prevented significant steatosis found in WD-fed mice. Accordingly, hepatic insulin signalling was deteriorated in WD-fed mice but not in WDE-fed mice. Empagliflozin supplementation positively affected size and morphology of mitochondria in skeletal muscle in both CD- and WD-fed mice.Empagliflozin protects mice from diet-induced weight gain, insulin resistance and hepatic steatosis in a preventative setting and improves muscle mitochondrial morphology independent of the type of diet." @default.
• W4311662008 created "2022-12-27" @default.
• W4311662008 creator A5010240915 @default.
• W4311662008 creator A5013439619 @default.
• W4311662008 creator A5015561955 @default.
• W4311662008 creator A5047666667 @default.
• W4311662008 creator A5048075329 @default.
• W4311662008 creator A5050626665 @default.
• W4311662008 creator A5058493851 @default.
• W4311662008 creator A5060473284 @default.
• W4311662008 creator A5062003804 @default.
• W4311662008 creator A5068288017 @default.
• W4311662008 creator A5068637529 @default.
• W4311662008 creator A5069675212 @default.
• W4311662008 creator A5070526191 @default.
• W4311662008 creator A5081148181 @default.
• W4311662008 creator A5082158981 @default.
• W4311662008 creator A5083883838 @default.
• W4311662008 creator A5084094746 @default.
• W4311662008 date "2022-12-16" @default.
• W4311662008 modified "2023-10-01" @default.
• W4311662008 title "Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis" @default.
• W4311662008 cites W1943654307 @default.
• W4311662008 cites W1976109106 @default.
• W4311662008 cites W2014791035 @default.
• W4311662008 cites W2022419155 @default.
• W4311662008 cites W2027545319 @default.
• W4311662008 cites W2067740038 @default.
• W4311662008 cites W2084611866 @default.
• W4311662008 cites W2099215299 @default.
• W4311662008 cites W2105364942 @default.
• W4311662008 cites W2126210788 @default.
• W4311662008 cites W2142025433 @default.
• W4311662008 cites W2146264128 @default.
• W4311662008 cites W2150430982 @default.
• W4311662008 cites W2154768987 @default.
• W4311662008 cites W2164368208 @default.
• W4311662008 cites W2167279371 @default.
• W4311662008 cites W2170096200 @default.
• W4311662008 cites W2210004938 @default.
• W4311662008 cites W2323606868 @default.
• W4311662008 cites W2575018533 @default.
• W4311662008 cites W2619744261 @default.
• W4311662008 cites W2625859604 @default.
• W4311662008 cites W2721533357 @default.
• W4311662008 cites W2735376054 @default.
• W4311662008 cites W2736811602 @default.
• W4311662008 cites W2738197400 @default.
• W4311662008 cites W2767674938 @default.
• W4311662008 cites W2808615577 @default.
• W4311662008 cites W2914961474 @default.
• W4311662008 cites W2936456541 @default.
• W4311662008 cites W2954922135 @default.
• W4311662008 cites W2967960051 @default.
• W4311662008 cites W2973671909 @default.
• W4311662008 cites W2981565698 @default.
• W4311662008 cites W2986499379 @default.
• W4311662008 cites W2989603136 @default.
• W4311662008 cites W2989691439 @default.
• W4311662008 cites W2992666626 @default.
• W4311662008 cites W3005425318 @default.
• W4311662008 cites W3043378534 @default.
• W4311662008 cites W3081830235 @default.
• W4311662008 cites W3102806899 @default.
• W4311662008 cites W3118300923 @default.
• W4311662008 cites W3121404945 @default.
• W4311662008 cites W3202575491 @default.
• W4311662008 cites W4220913390 @default.
• W4311662008 doi "https://doi.org/10.1007/s00125-022-05851-x" @default.
• W4311662008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36525084" @default.
• W4311662008 hasPublicationYear "2022" @default.
• W4311662008 type Work @default.
• W4311662008 citedByCount "2" @default.
• W4311662008 countsByYear W43116620082023 @default.
• W4311662008 crossrefType "journal-article" @default.
• W4311662008 hasAuthorship W4311662008A5010240915 @default.
• W4311662008 hasAuthorship W4311662008A5013439619 @default.
• W4311662008 hasAuthorship W4311662008A5015561955 @default.
• W4311662008 hasAuthorship W4311662008A5047666667 @default.
• W4311662008 hasAuthorship W4311662008A5048075329 @default.
• W4311662008 hasAuthorship W4311662008A5050626665 @default.
• W4311662008 hasAuthorship W4311662008A5058493851 @default.
• W4311662008 hasAuthorship W4311662008A5060473284 @default.
• W4311662008 hasAuthorship W4311662008A5062003804 @default.
• W4311662008 hasAuthorship W4311662008A5068288017 @default.
• W4311662008 hasAuthorship W4311662008A5068637529 @default.
• W4311662008 hasAuthorship W4311662008A5069675212 @default.
• W4311662008 hasAuthorship W4311662008A5070526191 @default.
• W4311662008 hasAuthorship W4311662008A5081148181 @default.
• W4311662008 hasAuthorship W4311662008A5082158981 @default.
• W4311662008 hasAuthorship W4311662008A5083883838 @default.
• W4311662008 hasAuthorship W4311662008A5084094746 @default.
• W4311662008 hasBestOaLocation W43116620081 @default.
• W4311662008 hasConcept C126322002 @default.
• W4311662008 hasConcept C134018914 @default.
• W4311662008 hasConcept C171089720 @default.
• W4311662008 hasConcept C2775887513 @default.
• W4311662008 hasConcept C2776175330 @default.

• next